Alcohol Pharmacology Acute and Chronic use and the effects on Anaesthesia Alcohol withdrawal.

Slides:



Advertisements
Similar presentations
Alcohol: Research to Practice Gail D’Onofrio MD, MS Section of Emergency Medicine Yale University School of Medicine.
Advertisements

Best Practice Tom Shiffler, MD 7/23/10
Toxin-Induced Seizures: Life-Threatening Forms of Withdrawl ACEP Scientific Assembly 2003, Boston, MA.
Opioids & Sedatives Toxicity
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Antianxiety Agents.
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial Journal Club 09/01/11 JAMA, February 4, 2009—Vol 301, No
Management of Alcohol Withdrawal
Addiction & Alcoholism. I. Addiction and its Two Key Forms A. Addiction: a condition in which an individual requires the use of a drug or the participation.
Chapter 5 Autonomic Drugs.
Drug-Induced Seizures (in 15 minutes or Less) Robert S. Hoffman, MD Director, NYC Poison Center Associate Professor Emergency Medicine and Medicine NYU.
Inpatient Management of Alcohol Withdrawal
CNS depressants CNS depressants
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 16 Anticonvulsants.
CIWA Protocol: Fraser Health
Anti-Anxiety Agents and Sedative-Hypnotics
Chapter 9 Alcohol Acute effects Mechanisms of action Long-term effects
 BNZ-1 r.: sedation, hypnotic, antianxiety  BNZ-2 r.: anxiolysis, muscle relaxation, sedation, anticonvulsant, psychomotor impairment  BNZ-3 r.: tolerance,
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2.
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES
Anesthesia and the Addict Howard F. Armour CRNA, MS.
Alcohol Dr Alison Battersby.
Ch 8 Drugs for Central Nervous System Disorders Epilepsy Parkinson Disease Other Central Nervous System Disorders Other Central Nervous System Disorders.
Clinical Experience of Novel Psychoactive Substances Dr Richard Stevenson.
Mechanism of action It interacts with specific receptors in the CNS, particularly in the cerebral cortex. Benzodiazepine-receptor binding enhances the.
Sedative-Hypnotic Drugs
Anti-Anxiety Medications Brian Ladds, M.D.. Anti-Anxiety Medications 1903: first barbiturate introduced in U.S. –e.g., pentobarbital (Nembutal), amobarbital.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
AddictionPresentedby Dr/ Said Said Elshama Dr/ Said Said Elshama.
Drugs used in treatment of addiction
Agents Used to Treat Seizures and Epilepsy Chapter 31.
LOGO Sedation in the ICU Prof. Bahaa Ewees Ain Shams University.
Substance abuse. Substance abuse, dependence, withdrawal, tolerance, and demographics Substance abuse, dependence, withdrawal, tolerance, and demographics.
Antipsychotic agents By S.Bohlooli PhD.
Anxiolytic , Sedative and Hypnotic Drugs
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
Fate of Local Anesthetics
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF CNS part 1 General Pharmacology M212.
Samantha Mohammad And Jack Utz
Liaison and Emergency Psychiatry Moray 1 Alcohol dependence and Safe Withdrawal In-patient detox in Dr Grays.
Introduction 1 person in 20 will have an epileptic seizure at some time in their life Epilepsy is diagnosed on the basis of two or more epileptic seizures.
Samantha Allen PharmD Candidate 2012 Case Presentation April 19, 2012 Alcohol Withdrawal Management.
ALCOHOL WITHDRAWAL: PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT
Drugs Used in Autism and Other Neurological diseases Dr. Yieldez Bassiouni.
Managing Alcohol and Opioid Withdrawals
ANTIEPLEPTICS Anticonvulsants. Epilepsy is a common neurological abnormality affecting about 1% of the human population. Epilepsy is a chronic, usually.
Sedation and Delirium Management
Anxiolytic , Sedative and Hypnotic Drugs
Chemical Dependence Process. Use of benzodiazepines u Not for chronic anxiety disorders u Not for the elderly u Not for depression u For short-term treatment.
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
ANTICONVULSANTS/ ANTISEIZURE Agents EPILEPSY: Disorder of Brain function (a disease) characterized by periodic and unpredictable occurrence of seizures.
ALCOHOLISM Alcoholism is a chronic disease characterized
Managing Alcohol and Opioid Withdrawals
Addiction & Alcoholism
Substance-Related AND Addictive Disorders/Drug Abuse
Anxiolytics, Sedatives and Hypnotic
Following this training the nurse will be able to:
Analysis of Safety and Efficacy of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal in ICU Vincent Rizzo MD MBA FACP Ricardo Lopez MD FCCP.
ANTI-SEIZURE MEDICATIONS
Treatment of Parkinson’s disease
Chapter 38 Drug Abuse II: Alcohol 1.
Sedation and Anagesia in Critical Care
Drugs Affecting the Central Nervous System
Anxiolytic, Sedative and Hypnotic Drugs
Drugs that act on ionotropic receptors
Chapter 5 Autonomic Drugs.
Alcohol Use Disorder Assessment & Treatment Strategies
Anxiolytic and hypnotic drugs
Anxiolytic, Sedative and Hypnotic Drugs
Sedative and hypnotic [hip‘nɔtik] drugs 镇静催眠药
Opioids & Sedatives Toxicity
Presentation transcript:

Alcohol Pharmacology Acute and Chronic use and the effects on Anaesthesia Alcohol withdrawal

http://www.edserv.musc.edu/clinpk/resources/zero_order/unit1.lasso

Consequences of high Acetaldehyde Poor mitochondrial function Results in less conversion to acetic acid – vicious cycle ? Role in addiction – altered neurotransmitters that resemble morphine

Oxidative phosphorylation ETC

Implications for anaesthesia?

Metabolic complications Alcoholic ketoacidosis (AKA) Electrolyte disorders (eg, hypomagnesemia, hypokalemia, hypernatremia) Vitamin deficiencies (eg, thiamine, phytonadione, cyanocobalamin, folic acid) GI complications Pancreatitis Gastrointestinal bleeding (eg, peptic ulcer, esophageal varices, gastritis) Hepatic cirrhosis Infectious complications Pneumonia Meningitis Cellulitis Neurologic complications Wernicke-Korsakoff syndrome (Confusion,ataxia,opthalmoplegia) Cerebral atrophy Cerebellar degeneration Subdural or epidural hemorrhage Peripheral neuropathy

Alcohol Withdrawal Mild withdrawal usually occurs within 24 hours of the last drink and is characterized by tremulousness (shakes), insomnia, anxiety, hyperreflexia, diaphoresis, mild autonomic hyperactivity, and GI upset. Moderate withdrawal usually occurs 24-36 hours after the cessation of alcohol intake and includes intense anxiety, tremors, insomnia, and excessive adrenergic symptoms. Severe withdrawal usually occurs more than 48 hours after a cessation or decrease in alcohol consumption. It is characterized by profound alteration of sensorium including disorientation, agitation, and hallucinations; along with severe autonomic hyperactivity including tremulousness, tachycardia, tachypnoea, hyperthermia, and diaphoresis.

Some ‘useful’ facts? 25% of patients with a prolonged history of alcohol abuse have alcoholic hallucinosis - not necessarily followed by DT 23-33% of patients with significant alcohol withdrawal have alcohol withdrawal seizures ("rum fits") - typically terminate spontaneously or are easily controlled with benzodiazepines Status epilepticus < 3% - Ix for other cause DT occurs 48-72 hours after the last drink. Includes all early and intermediate symptoms of alcohol withdrawal and a profoundly altered sensorium (disorientation, agitation, and hallucination). Severe autonomic derangements (including diaphoresis, tachycardia, tachypnea, and hyperthermia) are common DT may present without preceding seizures

Delirium Tremens altered mental status (global confusion) and sympathetic overdrive (autonomic hyperactivity) medical emergency with a high mortality rate Chronic Etoh - Increased release of endogenous opiates; activation of the GABA-A receptor and a decrease in GABA-A receptor function, with a resultant influx of Cl ions; Inhibition of the NMDA glutamate receptor (mediates the postsynaptic excitatory effects of glutamate) with up-regulation; and interactions with 5HT and DA receptors. Withdrawal from alcohol - loss of GABA-A receptor stimulation causes a reduction in chloride flux and is associated with tremors, diaphoresis, tachycardia, anxiety, and seizures; lack of inhibition of the NMDA receptors may lead to seizures and delirium. Excessive nervous system excitability during periods of abstinence from alcohol is related to the effect of alcohol on the number and function of brain receptors.

Pharmacological Rx ABC…DEFG…. Thiamine! Benzos (lorazepam, diazepam, oxazepam, chlodiazepoxide, midazolam) These drugs produce sedative effects by enhancing GABA neurotransmission from binding to GABAA receptors. All benzodiazepines appear similarly effective in the treatment of alcohol withdrawal syndrome. In moderate-to-severe withdrawal, long-acting agents are preferred over short-acting drugs. Symptom-triggered therapy is preferred over fixed-schedule therapy because it decreases the duration and total dose of treatment to resolve symptoms. Fixed-dose therapy is appropriate in mild-to-moderate withdrawal. Propofol (glutamate + GABA-A), barbiturate - refractory Haloperidol (QT and seizure threshold), carbamazepine, valproic acid, clonidine, and beta-blockers, MgSO4 - not as single agents gabapentin, pregabalin – awaiting more data Ethanol – inferior and not recommended Dexmedetomidine?

Dexmedetomidine- The new magnesium? 8 times more selective for the α2-receptor than clonidine Produces sedation, anxiolysis, and sympatholysis through agonism of central presynaptic α2-autoreceptors with no activity at GABA or opioid receptors - sedation without respiratory compromise Animal Studies: superior to propranolol in reducing withdrawal symptoms, strengthening the theory that dexmedetomidine may have a benefit in alcohol withdrawal outside of just decreasing elevated noradrenergic tone Case Studies: may allow for a reduction in benzodiazepine doses, as well as reduce the need for other adjunctive medications, such as anticonvulsants and antipsychotics

No registration or RCTs Problems The good news Initial loading dose - bradycardia and hypertension due to effect on peripheral α2b-receptors in vascular smooth muscle . Is a load necessary? No benefit in the prevention or treatment of alcohol withdrawal seizures or delirium tremens No registration or RCTs Adverse effect profile compares well with that of other options Midazolam: drug accumulation - difficult awakenings; Barbiturates: narrow therapeutic index and respiratory depression; Lorazepam infusions: propylene glycol toxicity and metabolic acidosis; Propofol: hypertriglyceridemia, pancreatitis, and propofol infusion syndrome Has been used without additive toxicity in combination with a variety of different medications (benzodiazepines, propofol, fentanyl, and morphine)

The Verdict? Role for α2-agonists is as adjunctive medication to benzodiazepines “Positive findings from case reports on use of dexmedetomidine, coupled with its ease of use, safety profile, and lack of intubation requirements, make this medication a valuable choice for alcohol withdrawal in the ICU”

Methanol/ethylene glycol HAGMA Osmolar Gap > 10 Measured osmolality - Calculated osmolality 2x Na + Glucose + Urea Treat with ethanol or dialysis